240 related articles for article (PubMed ID: 18564453)
41. Multiple Myeloma: Multiplying Therapies.
Bates SE
Clin Cancer Res; 2016 Nov; 22(22):5418. PubMed ID: 28151708
[No Abstract] [Full Text] [Related]
42. Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004.
Haas M; Lonial S
Expert Opin Investig Drugs; 2005 Sep; 14(9):1161-9. PubMed ID: 16144500
[TBL] [Abstract][Full Text] [Related]
43. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA; June 2-6, 2006.
Reddy GK; Tyagi P
Clin Genitourin Cancer; 2006 Jun; 5(1):18-22. PubMed ID: 16859574
[No Abstract] [Full Text] [Related]
44. [Is there any real progress in the chemotherapy of multiple myeloma?].
Bataille R
Rev Med Interne; 1985 Oct; 6(4):419-26. PubMed ID: 3906819
[No Abstract] [Full Text] [Related]
45. American society of hematology-45th annual meeting and exposition: hematological malignancies.
Davies J
IDrugs; 2004 Jan; 7(1):1-3. PubMed ID: 14968766
[No Abstract] [Full Text] [Related]
46. 43rd Annual Meeting of the American Society of Hematology, December 7-11, 2001, Orlando, Florida.
D'Orazio AI; Fisher MD
Clin Lymphoma; 2002 Mar; 2(4):205-8. PubMed ID: 11970758
[No Abstract] [Full Text] [Related]
47. [Therapeutic news in multiple myeloma. Congress of the French National Society of Internal Medicine, December 2008, Bordeaux].
Geffray L
Rev Med Interne; 2009 May; 30(5):465-8. PubMed ID: 19349101
[No Abstract] [Full Text] [Related]
48. Highlights of the American Society of Clinical Oncology annual meeting 2005. 13-17 May, 2005, Florida, USA.
Burstein HJ
Expert Rev Anticancer Ther; 2005 Aug; 5(4):581-3. PubMed ID: 16111459
[No Abstract] [Full Text] [Related]
49. Updates from the 2019 American Society of Clinical Oncology and European Hematology Association annual meetings: a Canadian perspective on high-risk cytogenetics in multiple myeloma.
LeBlanc R; Song K; White D; Christofides A; Doucette S
Curr Oncol; 2019 Aug; 26(4):e581-e594. PubMed ID: 31548829
[TBL] [Abstract][Full Text] [Related]
50. Lenalidomide for multiple myeloma.
Bertolini F
N Engl J Med; 2012 Aug; 367(6):573; author reply 573-5. PubMed ID: 22873542
[No Abstract] [Full Text] [Related]
51. A practical update on the use of bortezomib in the management of multiple myeloma.
San Miguel J; Bladé J; Boccadoro M; Cavenagh J; Glasmacher A; Jagannath S; Lonial S; Orlowski RZ; Sonneveld P; Ludwig H
Oncologist; 2006 Jan; 11(1):51-61. PubMed ID: 16401713
[TBL] [Abstract][Full Text] [Related]
52. FDA approves new agent for multiple myeloma.
Fenichel MP
J Natl Cancer Inst; 2015 Jun; 107(6):djv165. PubMed ID: 26032612
[No Abstract] [Full Text] [Related]
53. Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006.
Puglisi F; Andreetta C; Fasola G
Expert Opin Pharmacother; 2006 Nov; 7(16):2309-18. PubMed ID: 17059386
[TBL] [Abstract][Full Text] [Related]
54. New Treatments and Insights in Multiple Myeloma.
Faiman B; Noonan K
ONS Connect; 2016 Jun; 31(6):4 p following 31. PubMed ID: 27430103
[No Abstract] [Full Text] [Related]
55. Treatment of multiple myeloma and arterial thrombosis.
Raven W; Berghout A; van Houten A; Leebeek FW
Ann Hematol; 2010 Apr; 89(4):419-20. PubMed ID: 19688212
[No Abstract] [Full Text] [Related]
56. The American Society of Hematology--46th Annual Meeting and Exposition. HDAC, Flt and farnesyl transferase inhibitors.
Evans L
IDrugs; 2005 Jan; 8(1):4-6. PubMed ID: 15650931
[No Abstract] [Full Text] [Related]
57. [Development and current perspectives of treatment in multiple myeloma].
Sanz Marca A; López Alvarez J; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):225-9. PubMed ID: 6199817
[No Abstract] [Full Text] [Related]
58. Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma.
van der Spek E; Bloem AC; van de Donk NW; Bogers LH; van der Griend R; Kramer MH; de Weerdt O; Wittebol S; Lokhorst HM
Haematologica; 2006 Apr; 91(4):542-5. PubMed ID: 16585018
[TBL] [Abstract][Full Text] [Related]
59. Lenalidomide in myeloma--a high-maintenance friend.
Badros AZ
N Engl J Med; 2012 May; 366(19):1836-8. PubMed ID: 22571206
[No Abstract] [Full Text] [Related]
60. [Comparative evaluation of the effectiveness of mono- and polychemotherapy programs in patients with multiple myeloma].
Abdulkadyrov KM; Bessmel'tsev SS
Klin Med (Mosk); 1992; 70(9-10):57-60. PubMed ID: 1474818
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
